EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mosquito Salivary Proteins and Arbovirus Infection: From Viral Enhancers to Potential Targets for Vaccines

Alejandro Marín-López, Hamidah Raduwan, Tse-Yu Chen iD, Sergio Utrilla-Trigo, David P Wolfhard, Erol Fikrig

Pathogens · 23.02.2023 · 12 (3) · 371

DOI: 10.3390/pathogens12030371 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 23.02.2023. Verfasst von Alejandro Marín-López und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06519, USA. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, Howard Hughes Medical Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arthropod-borne viruses present important public health challenges worldwide. Viruses such as DENV, ZIKV, and WNV are of current concern due to an increasing incidence and an expanding geographic range, generating explosive outbreaks even in non-endemic areas. The clinical signs associated with infection from these arboviruses are often inapparent, mild, or nonspecific, but occasionally develop into serious complications marked by rapid onset, tremors, paralysis, hemorrhagic fever, neurological alterations, or death. They are predominately transmitted to humans through mosquito bite, during which saliva is inoculated into the skin to facilitate blood feeding. A new approach to prevent arboviral diseases has been proposed by the observation that arthropod saliva facilitates transmission of pathogens. Viruses released within mosquito saliva may more easily initiate host invasion by taking advantage of the host’s innate and adaptive immune responses to saliva. This provides a rationale for creating vaccines against mosquito salivary proteins, especially because of the lack of licensed vaccines against most of these viruses. This review aims to provide an overview of the effects on the host immune response by the mosquito salivary proteins and how these phenomena alter the infection outcome for different arboviruses, recent attempts to generate mosquito salivary-based vaccines against flavivirus including DENV, ZIKV, and WNV, and the potential benefits and pitfalls that this strategy involves.

Schlagwörter

Stichwörter der Autor:innen

arbovirusesimmune responsesmosquito salivavaccines

Autor:innen und Institutionen

  • Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06519, USA.
  • Center for Animal Health Research (CISA-INIA/CSIC), 28130 Madrid, Spain.
  • Faculty of Engineering Sciences, Institute of Pharmacy and Molecular Biotechnology, 69120 Heidelberg, Germany.

ORCID-Profile: Tse-Yu Chen

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • Howard Hughes Medical Institute
  • NIH
  • Steven and Alexandra Cohen Foundation
  • Howard Hughes Medical Institute Emerging Pathogens Initiative

Zitieren

APA

Marín-López, A., Raduwan, H., Chen, T. Y., Utrilla-Trigo, S., Wolfhard, D. P., & Fikrig, E. (2023). Mosquito Salivary Proteins and Arbovirus Infection: From Viral Enhancers to Potential Targets for Vaccines. Pathogens, 12(3), 371. https://doi.org/10.3390/pathogens12030371

Vancouver

Marín-López A, Raduwan H, Chen TY, Utrilla-Trigo S, Wolfhard DP, Fikrig E. Mosquito Salivary Proteins and Arbovirus Infection: From Viral Enhancers to Potential Targets for Vaccines. Pathogens. 2023;12(3):371. doi:10.3390/pathogens12030371

BibTeX
@article{MarnLpez2023,
  author = {Marín-López, Alejandro and Raduwan, Hamidah and Chen, Tse-Yu and Utrilla-Trigo, Sergio and Wolfhard, David P and Fikrig, Erol},
  title = {Mosquito Salivary Proteins and Arbovirus Infection: From Viral Enhancers to Potential Targets for Vaccines},
  journal = {Pathogens},
  year = {2023},
  volume = {12},
  number = {3},
  pages = {371},
  doi = {10.3390/pathogens12030371}
}
Kostenlos starten →